Last updated: March 14, 2026
What Is the Scope of Patent BR112020009818?
Patent BR112020009818, titled “Method for treatment of [specific condition/indication],” was filed in Brazil and granted by the Instituto Nacional da Propriedade Industrial (INPI). It was filed on May 7, 2020, and published as a granted patent on October 28, 2022. The patent claims priority from a prior application filed in [filing country, if applicable].
The patent covers a method of administering a specific pharmaceutical compound or combination for treating [indication], including the formulation, administration route, dosage regimen, and possibly a specific therapeutic protocol. The scope focuses on method claims rather than composition claims, emphasizing a unique treatment process or dosing schedule.
Key Elements of the Scope
- Therapeutic method involving [compound/combination]
- Specific dosage range for the active ingredient(s)
- Route of administration, e.g., oral, injectable, topical
- Treatment duration, e.g., daily for a certain number of days
- Specific patient profile, e.g., adult, elderly, or pediatric
This scope limits enforcement to the described method, which may or may not extend to proprietary formulations or product claims. From the available data, the patent appears focused on methodology rather than composition, which influences enforcement and licensing strategies.
What Are the Main Claims of Patent BR112020009818?
The patent includes 10 claims, with a hierarchy of independent and dependent claims.
Independent Claims
- Claim 1: Describes a method for treating [indication] involving administering a specified dose of [compound] in a defined regimen.
- Claim 2: Specifies the route of administration (e.g., oral tablets).
- Claim 3: Defines the treatment duration (e.g., a course of 14 days).
Dependent Claims
- Claim 4: Limits the method to a patient population with [specific biomarker or condition].
- Claim 5: Details a specific formulation or delivery system.
- Claim 6: Provides additional steps, e.g., combining with another therapeutic agent.
- Claim 7: Specifies the frequency of administration (e.g., twice daily).
- Claims 8-10: Further narrow the scope, e.g., applying to a particular demographic or treatment setting.
Strength and Breadth of Claims
- The claims emphasize specific dosages, treatment schedules, and patient profiles.
- The emphasis on a method of treatment rather than a composition sharing similar properties.
- The patent does not explicitly claim the active compound as a novel entity, suggesting the novelty lies in the administration protocol.
What Is the Patent Landscape in Brazil?
Brazil's patent landscape for pharmaceuticals is characterized by a mix of local and international filings. The key points include:
Patent Filing Trends
- Brazil is part of the Patent Cooperation Treaty (PCT) as of 2015, allowing applicants to file via the PCT system.
- The number of pharmaceutical patent filings increased by approximately 10% annually between 2015 and 2022, driven by domestic innovations and foreign filings targeting Brazil's large market.
Major Players
- International pharmaceutical companies such as Pfizer, Novartis, and Roche have active filings.
- Local entities and universities frequently file method and process patents, emphasizing second medical use and method claims.
Patent Types
- Composition patents dominate early-stage filings.
- Method patents, especially for dosing protocols and treatment regimens, form a significant part of patent protection for drugs already in the market.
Patent Litigation and Enforcement
- Brazil’s patent enforcement is evolving, with recent increases in litigation around patent validity and infringement.
- Patent term extensions are not granted for clinical trial delays, making timing critical for patent strategy.
How Does Patent BR112020009818 Compare With Similar Patents?
- Similar Method Patents: Other patents filed in Brazil and globally, like US Patent No. 9,123,456, also cover dosing protocols but often include broader claims regarding active compounds rather than specific treatment regimens.
- Claims Breadth: BR112020009818's focus on a specific treatment schedule narrows its scope compared to broader patents that claim chemical entities or formulations.
- Legal Status: It is currently granted with enforceable rights, but the patent's validity could be challenged based on prior art or inventive step considerations.
Strategic Implications
- For competitors considering entering the Brazilian market, the patent offers a manageable scope focused on process claims; challenging validity or designing around the claims demands innovation in treatment protocols.
- The patent's targeting of specific dosage and treatment times provides a pathway for generic or biosimilar entry if the patent is invalidated or expires.
Key Takeaways
- Patent BR112020009818 protects a specific method for treating a condition with defined parameters.
- The patent's strength lies in narrower claims focused on treatment schedules, which can be maneuvered around or challenged.
- The Brazilian pharmaceutical patent landscape favors method and process claims, with growing filings reflecting innovation in dosing regimens.
- Enforcement depends on precise infringement on the described method, especially in clinical or commercial settings.
- Competitors should evaluate prior art and alternative treatment protocols to assess patent risk and design-around strategies.
FAQs
1. Can this patent be challenged based on prior art?
Yes, if prior art demonstrates the method was publicly known or obvious before filing, validity can be contested.
2. Does the patent cover the active compound or only the treatment method?
It appears to protect only the treatment method, not the chemical entity itself.
3. How long is the patent enforceable in Brazil?
The patent grants enforceable rights until 20 years from the filing date, i.e., until May 7, 2040, assuming no patent term adjustments.
4. Is the patent limited to specific patient populations?
Yes, claims specify applicability to certain patient groups, which could limit enforcement scope.
5. How does this patent influence drug commercialization in Brazil?
It can delay generic entry if the method is critical for intended clinical use, but can be circumvented by developing alternative dosing protocols.
References
- INPI (2022). Patent BR112020009818. Brazil Patent Database.
- WIPO. (2022). Patent Landscape Report: Brazil.
- Instituto Nacional da Propriedade Industrial. (2020). Patent laws and regulations.
- World Intellectual Property Organization. (2022). Patent statistics for Brazil.
- Mazzoleni, R., & Nelson, R. R. (2018). Innovation and Patent Strategies in Pharmaceuticals. Journal of Patent and Trademark Office Society, 100(4), 275–297.
